Delivery Order SPE2DB20D2001-SPE2DB22FM71B

Award Date 8/30/22
Potential Completion Date 8/31/22
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The contracting agency is the Defense Logistics Agency (DLA), which is a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,818.40 and a completion date of December 13, 2024. The contract was awarded on December 12, 2024 and is a delivery order, with no...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 mL pen, with a ceiling value of $6,966.72. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (3 mg/0.5 ml pen, 0.5 ml) to the Defense Logistics Agency (DLA). The $2,543.34 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 22, 2023, with a completion date of December 26, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $5,825.04. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 3, 2023. This contract is not designated as a set-aside, indicating open competition....
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml, with a total value of $7,906.42. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides supplies and services to the U.S. military. This is a delivery order contract...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The $1,451.40 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 24, 2023 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen, 0.5 ml, to the Defense Logistics Agency (DLA). The $7,153.54 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 27, 2023, with a completion date of September 28, 2023. The contract is a firm fixed-price delivery order, not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,549.92 delivery order contract is with the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 8, 2022. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive...
This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, valued at $1,804.24. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award is for the delivery of the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $3,574.36. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through December 13, 2024 and is a firm fixed-price delivery order. The contract was not designated...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB22FM71B
    Delivery Order

This federal contract award is for the pharmaceutical product Trulicity 1.5 mg/0.5 mL pen with a 0.5 mL dosage. The $7,573.44 delivery order was awarded to prime contractor AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on August 30, 2022, with an ultimate completion date of August 31, 2022.

AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:38 PM